Terms: = Skin cancer AND FANCC, ENSG00000158169, 2176, RP11-80I15_2, FAC, FA3, FACC, FLJ14675 AND Prognosis
4213 results:
1. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract] [Full Text] [Related]
2. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.
Gómez-de Castro C; Santos-Juanes R; Nuñez-Gómez B; Fernández-Vega I; Vivanco B; Fernández-Velasco A; Reyes-García S; Carrero-Martín J; García-Pedrero JM; Rodrigo JP; González-Vela MDC; Santos-Juanes J; Galache C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673889
[TBL] [Abstract] [Full Text] [Related]
3. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
[TBL] [Abstract] [Full Text] [Related]
4. The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments.
Gefeller O; Kaiser I; Brockmann EM; Uter W; Pfahlberg AB
Curr Oncol; 2024 Apr; 31(4):2221-2232. PubMed ID: 38668067
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.
Ertekin SS; Mangas C; Riquelme-Mc Loughlin C; Carrera C; Malvehy J; Puig S; Podlipnik S
Acta Derm Venereol; 2024 Apr; 104():adv27571. PubMed ID: 38655656
[TBL] [Abstract] [Full Text] [Related]
6. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
Zhao M; Yu Y; Song Z
Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
[TBL] [Abstract] [Full Text] [Related]
7. Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
Nishimura T; Fujimoto H; Fujiwara T; Ito K; Fujiwara A; Yuda H; Itani H; Naito M; Kodama S; Furuhashi K; Yagi A; Saiki H; Yasuma T; Okano T; Tomaru A; Tanigawa M; Yoshida M; Hataji O; Ibata H; D'Alessandro-Gabazza CN; Gabazza EC; Kobayashi T
Cancer Med; 2024 Apr; 13(8):e7188. PubMed ID: 38629295
[TBL] [Abstract] [Full Text] [Related]
8. A chest CT-based nomogram for predicting survival in acute myeloid leukemia.
Yi X; Zhan H; Lyu J; Du J; Dai M; Zhao M; Zhang Y; Zhou C; Xu X; Fan Y; Li L; Dong B; Jiang X; Xiao Z; Zhou J; Zhao M; Zhang J; Fu Y; Chen T; Xu Y; Tian J; Liu Q; Zeng H
BMC Cancer; 2024 Apr; 24(1):458. PubMed ID: 38609917
[TBL] [Abstract] [Full Text] [Related]
9. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.
Hong S; Lee JH; Heo JY; Suh KJ; Kim SH; Kim YJ; Kim JH
J Cancer Res Clin Oncol; 2024 Apr; 150(4):186. PubMed ID: 38600328
[TBL] [Abstract] [Full Text] [Related]
10. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic nomograms for predicting long-term overall survival in spindle cell melanoma: a population-based study.
Lau WC; Huang L; Zheng X; Ming WK; Leong NC; Tak Wong Y; Yin Z; Yu H; Lyu J; Deng L
Front Endocrinol (Lausanne); 2024; 15():1260966. PubMed ID: 38572477
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma.
Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K
Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660
[TBL] [Abstract] [Full Text] [Related]
13. 5-Methylcytosine immunohistochemistry for predicting cutaneous melanoma prognosis.
Meevassana J; Varophas S; Prabsattru P; Kamolratanakul S; Ruangritchankul K; Kitkumthorn N
Sci Rep; 2024 Mar; 14(1):7554. PubMed ID: 38555324
[TBL] [Abstract] [Full Text] [Related]
14. CD146 as a prognostic marker in breast cancer: A meta-analysis.
Sharma A; Somasundaram I; Chabaud MB
J Cancer Res Ther; 2024 Jan; 20(1):193-198. PubMed ID: 38554320
[TBL] [Abstract] [Full Text] [Related]
15. Case report: A case of Paget disease outside the axillary breast.
Zhou Z; Zhou B; Wu X; Wei W
Medicine (Baltimore); 2024 Mar; 103(13):e37541. PubMed ID: 38552095
[TBL] [Abstract] [Full Text] [Related]
16. Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis.
Wu Z; Wang X; Wu H; Du S; Wang Z; Xie S; Zhang R; Chen G; Chen H
Comput Biol Med; 2024 May; 173():108307. PubMed ID: 38547657
[TBL] [Abstract] [Full Text] [Related]
17. Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.
Fabre M; Lamoureux A; Meunier L; Samaran Q; Lesage C; Girard C; Du Thanh A; Moulis L; Dereure O
Melanoma Res; 2024 Jun; 34(3):241-247. PubMed ID: 38546723
[TBL] [Abstract] [Full Text] [Related]
18. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
19. Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x
Peng Z; Gillissen B; Richter A; Sinnberg T; Schlaak MS; Eberle J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542429
[TBL] [Abstract] [Full Text] [Related]
20. GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure.
Jeong H; Cho YR; Gim J; Cha SK; Kim M; Kang DR
PLoS One; 2024; 19(3):e0291223. PubMed ID: 38536842
[TBL] [Abstract] [Full Text] [Related]
[Next]
